[e-drug] Drug price structure (cont'd)

[Kirsten Myhr <kirsten.myhr@relis.ulleval.no>]

E-drug: Drug price structure (cont'd)
-------------------------------------------------------------------------

Price composition will be monitored as part of the pricing project
launched by WHO and HAI, see press release posted on E-drug 20
May (www.essentialdrugs.org/edrug/archive/200305/msg00044.php). 

We have some data from the pilot studies but this is a very complex
issue in most developing countries, so good quality information is
difficult to obtain. E.g. many countries do not have fixed mark-ups.
While waiting for the data we collected in the pilot studies to be put on
the HAI website in a couple of weeks' time, there are three sources:

On the e-drug message from Libby Levison: Research paper
available: the hidden costs of procuring essential medicines
http://www.essentialdrugs.org/edrug/archive/200302/msg00003.php

European Commission 2002: Duties and taxes of essential medicines
used in the treatment of the major communicable diseases. European
Commission, Directorate-General for Trade, Brussels.
http://europa.eu.int/comm/trade/issues/global/medecine/docs/wtosub_
100303.pdf

Bale HE Jr. Consumption and trade in off-patented medicines. CMH
Working Paper Series. Paper no WG 4:3. May 2001
http://www3.who.int/whosis/cmh/cmh_papers/e/pdf/wg4_paper03.pdf
 
Kirsten Myhr, MScPharm, MPH
Head, RELIS Ost Drug Information Centre
Ulleval University Hospital
0407 OSLO, Norway
Tel: +47 23 01 64 11  Fax: +47 23 01 64 10
kirsten.myhr@relis.ulleval.no (w) 
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug